Table 1.
Demographics and concentrations of CCP3 and CCP3.1 and across all clinical groups.
| Variable | Cohort A - RA patients (n = 136) | Cohort A - Disease Controls (n = 195) | Cohort B (n = 81) |
|---|---|---|---|
| Age (years) Mean (range) |
55.7 (24–85) | 50.9 (13–84) | 51.1 (20–77) |
| Female sex, n (%) | 106 (78 %) | 127 (65 %) | 55 (68 %) |
| CCP3, mean units (median; range) | 118.5 (145.5; 1–267) | 8.4 (4; 1–174) | 130.1 (157.0; 3–216) |
| CCP3.1, mean units (median; range) | 110.0 (108.5; 5–237) | 11.6 (7.9; 4–211) | 137.6 (165.6; 6–230) |
| CCP3 positive n (%) | 107 (79 %) | 18 (9 %) | 72 (89 %) |
| CCP3.1 positive n (%) | 106 (78 %) | 13 (7 %) | 74 (91 %) |